Anebulo Pharmaceuticals Stock Forum

$Anebulo Pharmaceuticals (ANEB.US)$
On December 22, 2024, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with 22NW Fund, LP (“22NW”), a greater than 5% stockholder of the Company that is controlled by Aron English, a director of the Company, as well as other institutional accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors, in a private place...

$Anebulo Pharmaceuticals (ANEB.US)$
Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
Monday, 23rd December at 9:15 am
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the "Company" or "Anebulo"), today announced a positive regulatory update and the close of a capital raise....

$Advent Technologies (ADN.US)$ $flyExclusive (FLYX.US)$ $Banzai International (BNZI.US)$ $Anebulo Pharmaceuticals (ANEB.US)$ $Jin Medical International (ZJYL.US)$ $ShiftPixy (PIXY.US)$ $Gaxos.ai (GXAI.US)$   $Scilex Holding (SCLX.US)$ $PAVmed (PAVM.US)$
📊⚡️📊

$Anebulo Pharmaceuticals (ANEB.US)$ Anebulo Receives $1.9M Grant From NIDA For Investigational IV Treatment Of Cannabis Toxic Effects
Benzinga· just

$Anebulo Pharmaceuticals (ANEB.US)$ Anebulo Pharmaceuticals Filed U.S. Patent Application #20240010617: Crystalline Forms Of A Cannabinoid Receptor Type 1 (Cb1) Modulator And Methods Of Use And Preparation Thereof

$Anebulo Pharmaceuticals (ANEB.US)$ Anebulo Receives Positive Feedback From FDA On Path To Advance Phase 3 Clinical Development Of ANEB-001 And Completes Dosing Of Phase 2 Extension.

$Anebulo Pharmaceuticals (ANEB.US)$ Target achieved

$Anebulo Pharmaceuticals (ANEB.US)$$8.70 target price
#phase 2
#phase 3 end of 2021